Risk of dementia by body mass index (BMI) at midlife (age 50 years).
Risk of dementia by body mass index (BMI) at late life (age 65 years or older).
Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O’Meara ES, Longstreth WT, Luchsinger JA. Midlife and Late-Life Obesity and the Risk of DementiaCardiovascular Health Study. Arch Neurol. 2009;66(3):336–342. doi:10.1001/archneurol.2008.582
While high adiposity in middle age appears to be related to greater dementia risk, studies exploring this association in the elderly are conflicting.
To evaluate associations between midlife and late-life obesity and risk of dementia.
Prospective study with mean follow-up of 5.4 years (1992-1994 through 1999).
Community-dwelling sample in 4 US sites recruited from Medicare eligibility files.
A total of 2798 adults without dementia (mean age, 74.7 years; 59.1% women) participating in the Cardiovascular Health Study who underwent magnetic resonance imaging were measured for height and weight at baseline at age 65 years or older (late life), and self-reported weight at age 50 years (midlife). Body mass index (BMI) (calculated as weight in kilograms divided by height in meters squared) was calculated at both times.
Main Outcome Measures
Dementia, Alzheimer disease, and vascular dementia classified by a multidisciplinary committee using standardized criteria.
Classification resulted in 480 persons with incident dementia, 245 with Alzheimer disease (no vascular dementia), and 213 with vascular dementia (with or without Alzheimer disease). In evaluations of midlife obesity, an increased risk of dementia was found for obese (BMI >30) vs normal-weight (BMI 20-25) persons, adjusted for demographics (hazard ratio [HR], 1.39; 95% confidence interval [CI], 1.03-1.87) and for cardiovascular risk factors (1.36; 0.94-1.95). The risk estimates were reversed in assessments of late-life BMI. Underweight persons (BMI <20) had an increased risk of dementia (1.62; 1.02-2.64), whereas being overweight (BMI >25-30) was not associated (0.92; 0.72-1.18) and being obese reduced the risk of dementia (0.63; 0.44-0.91) compared with those with normal BMI.
These results help explain the “obesity paradox” as differences in dementia risk across time are consistent with physical changes in the trajectory toward disability.
Dementia prevalence will quadruple by 2047.1 Obesity, hyperinsulinemia, and diabetes mellitus are increasing worldwide.2- 5 High adiposity predicts hyperinsulinemia and diabetes mellitus,6 both risk factors for dementia.7- 12 Although high adiposity in middle age seems to be related to greater dementia risk,13,14 studies that explore this association in the elderly are conflicting.15- 18 Several reasons may explain these inconsistencies: (1) body mass index (BMI) may not be a good measure of adiposity in elderly people,19 (2) the association between high BMI and adverse outcomes may be attenuated with age,20 and (3) low BMI is a marker of weight loss, frailty, and preclinical dementia.21,22
The term obesity paradox was coined after several studies23- 25 reported that excess weight, traditionally considered detrimental to health, predicted survival in elderly persons. The Cardiovascular Health Study (CHS) allowed us to examine the obesity paradox in dementia because it collected BMI from participants at midlife and late life. In addition, adiposity was clinically measured several ways in late life. We sought to evaluate the associations between midlife and late-life BMI and the risk of dementia, Alzheimer disease (AD), and vascular dementia (VaD).
The CHS, a multisite observational study of 5888 adults 65 years and older,26 was initiated in 1989. The CHS recruited 5201 participants during its initial wave from Medicare eligibility lists in 4 US communities: Forsyth County, North Carolina; Washington County, Maryland; Sacramento County, California; and Pittsburgh, Pennsylvania.27 In 1992-1993, 687 African American individuals were recruited. From baseline (1989-1990) until 1998-1999, up to 10 annual clinic visits were completed. Data collected at these examinations each year included demographics, anthropometric measurements, vital signs, cognitive function, information from psychosocial interviews, depression level, medical history, and physical function. Phlebotomy was performed for laboratory analyses. Surveillance and collection of events data were ongoing.28 All the participants completed an informed consent form, and institutional review board approvals were received from all the sites. A separate, completed DNA consent form was obtained for genetic studies.
In 1998-1999, dementia was classified in 3602 CHS participants as a part of the CHS Cognition Study.29,30 Inclusion in the CHS-Cognition cohort required completion of cranial magnetic resonance imaging (MRI) and the modified Mini-Mental State Examination (MMSE) in 1992-1994. These participants were screened using data collected at the visit closest to MRI to identify those at higher risk who were asked to return to the clinic for additional cognitive testing. An individual was considered to be at high risk for dementia if he or she had previously scored less than 80 or had a decrease of 5 or more points on the modified MMSE administered at previous examinations, a previous Telephone Interview for Cognitive Status score of less than 28 or an Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) score of greater than 3.6, incident stroke, or current residence in a nursing home. A battery of neuropsychiatric tests was administered to those agreeing to return to the clinic or to receive a home visit. The following examinations were used: the American version of the National Reading Test, Raven's Colored Progressive Matrices, California Verbal Learning Test, Rey-Osterreith Figure, immediate and delayed recall, modified Boston Naming Test, verbal fluency test, block design (modified from the Wechsler Adult Intelligence Scale–Revised), Stroop Neuropsychological Screening Test, Trail Making Test, digit spans, and Baddeley and Papagno divided attention task. Methods to evaluate persons who declined the neuropsychiatric battery or who were no longer living included a medical record review of all hospitalizations, questionnaires sent to the personal physician, and standardized interviews by telephone with the participants (if living) or a designated informant (Telephone Interview for Cognitive Status, Neuropsychiatric Inventory, or IQCODE). In addition, all prospectively collected data from inception of the CHS were reviewed to provide additional information on cognitive decline during the 10 years of follow-up, including repeated measures of the modified MMSE, Digit Symbol Substitution Test, Benton Visual Retention Test, Trails A and B, Center for Epidemiologic Studies Depression Scale, medications inventory, activities of daily living, instrumental activities of daily living, other physical function measures (gait speed, balance tests, grip strength, etc), and documentation of hospitalized medical events, such as strokes, myocardial infarctions, etc. All data were compiled into packets for review during the classification process.
Dementia classification was completed by consensus of neurologists and psychiatrists using data from the neuropsychiatric tests or by other data as noted previously herein for deceased participants or those unable to come into the clinic. Cranial MRIs were used for classification of dementia subtype. All AD was classified using National Institute of Neurological and Communicative Diseases and Stroke–Alzheimer Disease and Related Disorders Association criteria.31 All VaD was classified using State of California Alzheimer's Disease Diagnostic and Treatment Centers criteria.32 Dementia onset was determined by review of the longitudinal data collected during the 10 years of study follow-up and by family input using the Neuropsychiatric Inventory. If date of onset was determined to be before entry into the CHS-Cognition cohort, the participant was determined to have prevalent dementia at baseline.
Anthropometric measurements in late life were collected in person at the clinic visit occurring closest to the time of the CHS MRI. These measures included standing height, weight, and waist-hip circumference in 1992-1993 (baseline for the CHS-Cognition). Midlife weight, however, relied on self-report of weight at age 50 years collected on the medical history form. Midlife BMI was estimated using this self-report of participants' “usual” weight at age 50 years and height measured at study baseline. The BMI was calculated as weight in kilograms divided by height in meters squared, and waist-hip ratio (WHR) as the ratio of waist to hip circumference. The BMI was also categorized into 4 groups: underweight (<20), normal weight (20-25), overweight (>25-30), and obese (>30) based on recommendations for older adults.33 Time to dementia was calculated in days from entry into the CHS-Cognition cohort until dementia onset, death, or July 1, 1999 (end of dementia follow-up).
Covariates examined included self-reported age, race (white vs nonwhite), sex, and educational level; diabetes mellitus was ascertained using the American Diabetes Association definition. Hypertension was defined as systolic blood pressure greater than 140 mm Hg or diastolic blood pressure greater than 190 mm Hg. Coronary heart disease was based on a history of myocardial infarction, angina, coronary bypass surgery, or angioplasty. Total cholesterol, C-reactive protein, and interleukin 6 levels and apolipoprotein E genotype were assayed by the CHS central laboratory.34 Smoking status was self-reported (current, previous, or never). The ankle-arm index was calculated using blood pressure at the brachial artery and ankle.35
Of the 3602 participants in the CHS-Cognition, 227 with prevalent dementia on MRI and 577 with mild cognitive impairment were excluded. We calculated descriptive statistics for demographics and comorbidities by category of BMI. The χ2 test and analysis of variance were used to determine bivariate differences. The sample size for these analyses included 2798 persons: 480 with dementia and 2318 without dementia throughout follow-up. Cox proportional hazards regression was used to estimate the risk of dementia associated with BMI at midlife and late life as continuous and categorical variables. We also examined WHR as an exposure. Models were adjusted for demographics (age, sex, race, and educational level) and cardiovascular and dementia risk factors (including history of hypertension, diabetes mellitus status, coronary heart disease, total cholesterol level, ankle-arm index, C-reactive protein level, interleukin 6 level, smoking status, kilocalories expended per week, and apolipoprotein E genotype). For dementia subtype, persons were censored at onset of VaD in models evaluating AD and for AD in models of VaD. All the analyses were performed using a software program (SPSS version 13.0; SPSS Inc, Chicago, Illinois).
Of the 2798 participants included in the analyses, 480 were classified with incident dementia during a mean of 5.4 years of follow-up. Of these, 245 were determined to have pure AD (AD without VaD), 62 with pure VaD (VaD without AD), and 151 with AD and VaD, or mixed dementia. Due to the low number of cases with pure VaD, these were combined with mixed dementia to provide 213 cases for VaD-specific models. The age of the participants ranged from 65 through 97 years (mean [SD], 74.7 [4.8] years); 59.1% were women, 10.1% were African American, and 10.5% were nonwhite. Less than one-third of the sample (n = 920) had a normal BMI at baseline, whereas only 117 (4.2%) were underweight, 1207 (43.1%) were overweight, and 554 (19.8%) were obese.
Table 1 provides characteristics of the study sample by BMI category. The BMI was related to primary demographics (age, sex, race, and educational level), other risk factors for cardiovascular disease (ankle-arm index, history of diabetes, history of hypertension, and smoking status), and measures of inflammation (C-reactive protein and interleukin 6). The BMI was not related to a history of coronary heart disease or the presence of the apolipoprotein E ε4 allele.
Higher midlife BMI was not associated with lower dementia risk using BMI as a continuous variable adjusted for demographics and cardiovascular risk factors (hazard ratio [HR] per BMI unit, 1.01; 95% confidence interval [CI], 0.98-1.04) (Table 2). However, in the categorical models, being obese was associated with a 40% increased risk of dementia adjusted for demographics (HR, 1.39; 95% CI, 1.03-1.87), as shown in Figure 1, although the association was attenuated in the fully adjusted model (1.36; 0.94-1.95). The relationships were similar for AD and VaD. Being underweight at midlife was not associated with dementia, AD, or VaD.
In contrast, an inverse relationship between late-life BMI as a continuous variable and incident dementia was found independent of demographics (HR per BMI unit, 0.97; 95% CI, 0.95-0.99) (Table 3). The association remained significant when adjusted for cardiovascular and dementia risk factors (HR, 0.95; 95% CI, 0.92-0.98). Adjusted for all covariates, being underweight (BMI <20) increased the risk of dementia by 60% (HR, 1.62; 95% CI, 1.02-2.64), whereas being overweight (BMI of >25-30) was not associated (0.92; 0.72-1.18) and being obese (BMI of >30) was associated with a reduced risk of dementia (0.63; 0.44-0.91) compared with being of normal weight (BMI of 20-25) (Figure 2). Results for the dementia subtypes were similar to those for total dementia. One difference was that higher estimates were produced in the models assessing VaD, suggesting that being underweight is a greater risk factor for VaD than for AD.
Significant associations were not found between WHR in late life and dementia, AD, or VaD (data not shown). Although the HR was close to 1.0 for the association between WHR and dementia, adjusting for demographics, the point estimate fell below 1.0 when adjusted for cardiovascular risk factors (HR, 0.71; 95% CI, 0.15-3.27). However, the 95% CIs were wide, and the association was not significant. Results were similar by dementia subtype.
The ability to evaluate BMI at 2 age categories in the CHS cohort provides insight into differences found in other studies and the obesity paradox. We found that whereas midlife obesity was related to higher dementia risk, BMI after age 65 years was inversely related. The greatest dementia risk was found in underweight individuals at older ages. These findings suggest that the predictive ability of BMI changes across time. High BMI in middle age has been found to be associated with higher dementia risk.13,14 Higher BMI at ages 70, 75, and 79 years has also been found to predict dementia,17 although there have been reports of no association,16 of lower BMI related to higher AD risk,15 and of a U-shaped relation between BMI and dementia at older ages.18 These conflicting findings could be explained by the different age groups observed in different studies; those conducted with middle-aged participants show a relation of high BMI to increased dementia risk, whereas those conducted with older populations differ. Whereas the association we found at midlife may be related to the emergence of conditions such as hypertension in middle age, the association of high BMI to cardiovascular and total mortality may be attenuated in older age groups, in which high BMI becomes a predictor of decreased mortality.20 However, the difference we found possibly may be due to the decreased value of BMI as a measure of adiposity in the oldest of the elderly. In addition, because associations we reported at midlife and late life involved the same individuals, these findings may also have been affected by changes in BMI with age, or they may reflect differences in the importance of exposure to high adiposity in middle age vs old age.
The curvilinear associations found in these results for late-life BMI are similar to those found by Sturman et al36 in a biracial cohort. This U-shaped association has been reported in other outcomes in older adults37 and helps explain the paradoxical findings between BMI and dementia. The relation of low BMI to worse outcomes is usually ascribed to conditions associated with weight loss. Higher BMI related to worse outcomes is usually interpreted as evidence of the consequences of obesity. The present study had the advantage of having had BMI measures at midlife and late life in the same persons; results are consistent with the body of literature showing that BMI in midlife is a predictor of dementia, whereas it is not at older ages. This study also supports the notion that important exposures related to a higher risk of dementia often occur in middle age, a period that is not assessed in most studies of aging. Thus, it is important to assess midlife exposures in studies of aging, either by enrolling participants at an earlier age, which has logistical and cost difficulties, or by including proxy measures of midlife exposures, such as subclinical markers or self-reported measures.
Aging is characterized by lean body mass loss and adipose tissue increase without weight gain, a phenomenon that is not captured by BMI. Thus, traditional adiposity measures are less useful in elderly individuals.38 Because measurements such as BMI may be less accurate in assessing obesity in elderly individuals, alternative anthropometric tools could be used. The highest quintile of sagittal abdominal diameter measured in midlife was associated with a 3-fold increased risk of dementia.39 Waist circumference and WHR have been proposed as better adiposity measures in elderly people.19,37,38 One study18 in New York City found that elevated waist circumference was related to higher dementia risk in persons aged 65 to 76 years, but not in those older than 76 years, and to higher risk of VaD in all age groups. We found no associations for WHR in old age.
Weight loss occurs with comorbidities at older ages and is often reflective of poor health. Weight loss, along with psychological, behavioral, and mobility problems, is one of the principal manifestations of AD.40 Weight loss may predate dementia onset by as much as 10 years.41 We found that whereas higher BMI at midlife may increase the risk of dementia, when measured after age 65 years, increased BMI may actually be a marker for decreased dementia risk.
The large sample and well-characterized CHS data are strengths of this study, but there are several limitations. Although we have treated BMI at midlife and late life equally, midlife weight was collected by self-report, so recall bias may have occurred. We did not have height at age 50 years, and midlife BMI was calculated using height at the CHS-Cognition baseline. Because height may be lost with aging, the midlife BMI estimate may be biased. However, elevated weight is protective against bone42 and height loss. Thus, biases in this study would be most relevant to underweight participants. The greater misclassification inherent in BMI at midlife (vs late life) may also have affected results found in these models. Thus, it is possible that the relatively weak associations found for midlife BMI understate the true relationships that would be observed in a cohort recruited at middle age and followed up through late life. We should also note here that the methods for ascertaining dementia and date of onset used in the CHS-Cognition were nontraditional and may have resulted in misclassification. However, this type of error would have attenuated models toward the null and would not have changed the overall conclusions.
Finally, the results of this study are relevant only to those who live beyond age 65 years without dementia, and generalizations should be made only to this group. Similarly, because nutritional status is related to morbidity and mortality in elderly persons, competing risks must be taken into consideration.
The associations between midlife and late-life BMI and risk of dementia reported herein are consistent with physical changes in the trajectory toward disability and frailty. These results reinforce the necessity of monitoring weight loss closely in older adults. These data also suggest the value of modified classification of “overweight” in the elderly because being overweight (compared with obese) may confer the same risk as being of normal weight for some diseases, including dementia. Clarification of the consequences of intentional vs unintentional weight loss is also needed to help guide clinical recommendations for older adults.
Correspondence: Annette L. Fitzpatrick, PhD, Department of Epidemiology, University of Washington, Collaborative Health Studies Coordinating Center, Bldg 29, Ste 310, 6200 NE 74th St, Seattle, WA 98115 (firstname.lastname@example.org).
Accepted for Publication: September 23, 2008.
Author Contributions: All authors had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Fitzpatrick, Kuller, and Lopez. Acquisition of data: Kuller. Analysis and interpretation of data: Fitzpatrick, Diehr, O’Meara, Longstreth, and Luchsinger. Drafting of the manuscript: Fitzpatrick, Lopez, O’Meara, and Luchsinger. Critical revision of the manuscript for important intellectual content: Fitzpatrick, Kuller, Lopez, Diehr, and Longstreth. Statistical analysis: Fitzpatrick, Lopez, Diehr, and O’Meara. Obtained funding: Kuller and Lopez. Administrative, technical, and material support: Fitzpatrick and Kuller. Study supervision: Fitzpatrick, Longstreth, and Luchsinger.
Financial Disclosure: None reported.
Funding/Support: The research reported in this article was supported by grant 5 R01 AG15928-02 from the National Institute on Aging and by contracts N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, and N01-HC-45133 and grant U01 HL080295 from the National Heart, Lung, and Blood Institute, with additional contributions from the National Institute of Neurological Disorders and Stroke.
Additional Information: A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm.